Xie, Yajun
Reid, Christopher M.
Turrero Garcίa, Miguel https://orcid.org/0000-0002-7294-169X
Dale-Huang, Fiona https://orcid.org/0000-0002-3656-1091
Granados, Alejandro A.
Lu, Yi https://orcid.org/0000-0003-0306-2621
Li, Jiwen
Hanson, Sarah M.
Mancia Leon, Walter R.
Liu, Jonathan
Adam, Manal
Mosto, Olivia
Pisco, Angela O.
Zhang, Ye https://orcid.org/0000-0002-1546-5930
Alvarez-Buylla, Arturo
Harwell, Corey C. https://orcid.org/0000-0002-8043-5869
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS118933)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R37MH119156)
Article History
Received: 6 November 2023
Accepted: 29 May 2025
First Online: 28 July 2025
Competing interests
: A.A.-B. is co-founder and a member of the scientific advisory board of Neurona Therapeutics. The other authors declare no competing interests.